To the list of publications


02 October

Pasteurellosis in Cattle

To ensure the stable development of a dairy farm, two essential conditions must be met: first, maintaining the health of the livestock at a high level, and second, producing high-quality, competitive products. The challenge in achieving both lies in the need for strict control over the animals’ health status, proper levels of milk production, culling and/or forced slaughter in cases of epizootic outbreaks. Among all infectious diseases of cattle, special attention should be paid to pasteurellosis, which has become widespread and causes significant economic losses in the dairy sector. According to current data, the disease is caused by two different types of microorganisms: Pasteurella multocida and Mannheimia haemolytica.

The pathogen M. haemolytica is still commonly known to many professionals as P. haemolytica and, together with P. multocida, is recognized as a key etiological factor of pasteurellosis. However, many farms still lack adequate information about M. haemolytica and its pathogenicity. While the characteristics of pasteurellosis caused by P. multocida have been well studied, there remains a lack of systematic data on the infectious pathology (mannheimiosis) caused by M. haemolytica. Particularly, the mechanisms of immunity formation and immunoprophylaxis remain insufficiently explored, and the effectiveness of specific preventive measures has not been fully proven. This situation often leads farm specialists into a dead end and results in the adoption of inappropriate control strategies for this infection.

Morphological Properties and Virulence Factors of the Pathogen

M. haemolytica, the most common causative agent of pasteurellosis, is divided into 3 biotypes, 12 biogroups, and 17 serotypes. According to experts, mannheimiosis is a pasteurellosis-like infectious disease that primarily affects the respiratory tract. Spanish researcher D. Casalta notes that the disease affects only ruminants, particularly cattle. P. multocida is also considered a dangerous pathogen. Scientists managed to isolate it from transtracheal wash samples from dairy calves under three months old — in 53% of cases with bovine respiratory disease complex (BRDC) and in 17% of healthy animals (Virtala et al.).

All Pasteurella species exhibit pleomorphism, meaning bacterial cells may appear in different shapes and sizes under the microscope. Typically, they are small gram-negative rods of ovoid or coccobacillary shape. G.R. Smith and colleagues reported that external environmental factors and the culture medium affect the shape and size of the pathogen. In nutrient-poor or low-temperature conditions, the culture tends to contain elongated rods or filaments, while in tissue samples or exudates, the bacteria most often appear as typical coccobacilli.

Like all Pasteurellaceae, M. haemolytica possesses virulence factors that aid in infection development in animals. The best-known of these include adhesins, neuraminidase, fimbriae, capsules, outer membrane proteins, proteases, lipopolysaccharides, and leukotoxins.

Clinical Course of the Disease Depends on the Etiological Agent

Infections of the bovine respiratory tract are most frequently caused by M. haemolytica serogroups A1 and A2 and P. multocida serogroups A and D (Fulton et al.; Reggiardo et al., 2005). Each pathogen has its own clinical peculiarities. M. haemolytica typically causes outbreaks of acute respiratory diseases, while P. multocida is more likely to cause pneumonia with a more subtle onset and chronic progression.

In cattle, three forms of pasteurellosis are distinguished: pulmonary, edematous, and intestinal. Sick animals exhibit a high fever (up to 41–42°C), tachycardia, general weakness, loss of appetite, swelling in the submandibular region, tongue, neck, and limbs, hypersalivation (in the edematous form), progressive anemia, constipation followed by diarrhea with blood (intestinal form, especially common in calves). The thoracic form is marked by symptoms of acute fibrinous pleuropneumonia: depression, appetite loss, labored breathing and rapid breathing, dry cough, and nasal discharge. Eventually, the discharge becomes purulent and bloody, diarrhea develops, and the animal usually dies within a few days. In subacute and chronic forms, the disease can last 2–3 months and is often fatal.

Expert Commentary

Oleksandr Deshchenko, veterinary doctor and livestock consultant at “VETSINTEZ” LLC 

I've worked at the company for over 10 years.

Pasteurellosis is a serious infectious disease that causes significant problems for Ukrainian farms. It’s a widespread issue in dairy herds, particularly among young cattle. The damage caused by pasteurellosis is enormous. Farms suffering from this infection for years face major issues with their young stock — high mortality, poor weight gain, and low health levels. Calf mortality can reach 90% when Pasteurella acts in combination with viruses, though pure pasteurellosis alone usually doesn't cause more than 20% mortality.

When a farm encounters pasteurellosis for the first time, all age groups may be affected — even adult cows. This leads to decreased milk production, breeding issues, and high abortion rates. It’s important to distinguish between primary pasteurellosis (rare) and secondary pasteurellosis, which is more common. The Pasteurella pathogen often acts as part of a "team" — viruses and mycoplasmas typically act as the primary agents, with Pasteurella joining later, worsening the disease in already weakened animals.

Risk factors include stress, poor hygiene, rodent infestation, and unbalanced feeding, all of which negatively impact the animal’s immune system. The most dangerous viral triggers are infectious bovine rhinotracheitis (IBR) and parainfluenza-3 (PI-3), which are followed by Pasteurella as a secondary invader.

In my opinion, vaccination is the only effective prevention, offering almost 100% protection. Unfortunately, this is a problematic area in Ukraine. Most combination vaccines lack the Pasteurella component. Monovalent vaccines also have their challenges, including logistics and manufacturing complexity — each farm must handle this issue individually, which isn’t easy.

Vaccination effectiveness depends on many factors: the animal’s individual response (especially under stress), the level of environmental pathogen pressure, proper vaccine storage, dosage, administration, and timing of vaccination and revaccination. Without good biosecurity, feeding, and stress management, even the best vaccination plan won’t work.

Besides vaccines, preventive antibiotic therapy is effective in high-risk areas. Considering the number of bacterial pathogens involved (including Pasteurella), metaphylactic treatment has proven both cost-effective and efficient in reducing BRDC cases. It is especially important in farms with known respiratory problems.

Typically, clinical signs of respiratory disease in calves appear between days 50–60 of life. Strategy should be based on each farm’s vaccination program:

  • If the herd is not vaccinated at all, metaphylaxis can start at day 14 of the calf's life.
  • If the maternal herd is vaccinated, antibiotics can be administered starting from day 30–35.

The drug of choice should be a long-acting broad-spectrum antibiotic. Our company recommends the injectable antibiotic Macrosept (active ingredient: tulathromycin), which offers a broad spectrum of action, rapid absorption, good distribution, and a prolonged effect of up to 20 days. It works in areas where mucous membranes meet oxygen (upper respiratory tract, lungs, bronchi, eyes, penis, anus, vulva). The recommended single dose for calves is 2.5 mg/kg or 1 ml per 40 kg of body weight (intramuscular or subcutaneous).